search

Targeted Metabolomics

We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.

NMR Metabolomics

From a single serum sample, we quantify multiple biomarkers, known and newly discovered. Precision Diagnostics.

AXINON® System

Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.

Learn more

Get your very own insight into our precision diagnostics approach.

The 6th edition of our customer journal is now available.

Our top topics:

  • Numares submitted #FDA 510(k) of NMR platform for metabolomics-based diagnostics
  • Bruker and numares sign agreement to bring NMR into clinical diagnostics
  • Published proof of concept: Novel, multi-marker approach to assess kidney disease allows for more precise GFR estimation
  • NMR series: Novelties for the AXINON® System preanalytical process

and many other interesting news.

Download

Back to list

You did not activate the necessary cookies for this content.

activate necessary cookies and show content